Product NDC: | 57664-437 |
Proprietary Name: | DIGOXIN |
Non Proprietary Name: | DIGOXIN |
Active Ingredient(s): | 125 ug/1 & nbsp; DIGOXIN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-437 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076363 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030731 |
Package NDC: | 57664-437-88 |
Package Description: | 100 TABLET in 1 BOTTLE (57664-437-88) |
NDC Code | 57664-437-88 |
Proprietary Name | DIGOXIN |
Package Description | 100 TABLET in 1 BOTTLE (57664-437-88) |
Product NDC | 57664-437 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DIGOXIN |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030731 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | DIGOXIN |
Strength Number | 125 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |